期刊名
Cancers

CANCERS

ISSN / eISSN
2072-6694
目标和范围
Cancers (ISSN 2072-6694) is an international, peer-reviewed open access journal on oncology. It publishes reviews, regular research papers and short communications. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced.
研究方向

肿瘤学

CiteScore
7.40 查看趋势图
CiteScore 学科排名
类别 分区 排名
Medicine - Oncology Q1 #90/366
Medicine - Cancer Research Q2 #82/214
Web of Science 核心合集
Science Citation Index Expanded (SCIE) Social Sciences Citation Index (SSCI)
Indexed -
类别 (Journal Citation Reports 2023) 分区
ONCOLOGY - SCIE Q2
H-index
53
出版国家或地区
Switzerland
出版商
MDPI (Basel, Switzerland)
出版年份
2009
年文章数
6140
Open Access
YES
通讯方式
ST ALBAN-ANLAGE 66, BASEL, SWITZERLAND, CH-4052
认证评论
注: 认证评论选取于全球各个学术评论平台和社交媒体。
Male tumor, almost all figures were done by bioinformatics, except for one dual staining of fluorescent mice tumor. It is a special project!

Uploaded on 2022.02.28
Received first peer review results on 2022.03.18. Two reviewers, one requested major revisions of experiments, and the other requested minor revisions. The editor gave us 10 days for major revisions, but due to some unexpected delays, we lost two days. Additionally, we had already started working on further projects and did not want to include the new images in the old article, so we rejected the request to add experiments, causing a delay in the submission. The reviewer's comments on major revisions were 7 pages long, while the reviewer for minor revisions had only 5 lines of questions, with three lines related to citations.

Received the second peer review results on 2022.03.29. The reviewer for major revisions still requested additional experiments, while the reviewer for minor revisions did not provide any comments. We were given 5 days for minor revisions. We added a relatively inferior figure. The reviewer for major revisions did not mention any language issues in the first review, but in the second review, they asked us to improve the language. However, our corresponding author is from Norway, and the second author is from the UK...

Accepted on 2022.04.06

Reviewer fee: 2400 CHF, approximately equivalent to around 17000 RMB at the exchange rate.
2022-04-06
How long does it take to have results under review? (What is the whole process like, can you please explain? Thank you)
2022-08-16

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now